{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T08:21:15Z","timestamp":1794385275722,"version":"4.9.0"},"publisher-location":"Berlin, Heidelberg","reference-count":130,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642164989","type":"print"},{"value":"9783642164996","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011]]},"DOI":"10.1007\/978-3-642-16499-6_21","type":"book-chapter","created":{"date-parts":[[2011,2,2]],"date-time":"2011-02-02T09:07:06Z","timestamp":1296637626000},"page":"453-483","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vasopressin Receptors in Voiding Dysfunction"],"prefix":"10.1007","author":[{"given":"Sailaja","family":"Pisipati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hashim","family":"Hashim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,19]]},"reference":[{"key":"21_CR1_21","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1053\/meta.2002.34052","volume":"51","author":"EA Abu-Basha","year":"2002","unstructured":"Abu-Basha EA, Yibchok-anun S, Hsu WH (2002) Glucose dependency of arginine vasopressin-induced insulin and glucagon release from the perfused rat pancreas. Metabolism 51:1184\u20131190","journal-title":"Metabolism"},{"issue":"1","key":"21_CR2_21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0021-9258(19)68038-5","volume":"233","author":"R Acher","year":"1958","unstructured":"Acher R, Light A, Du Vigneaud V (1958) Purification of oxytocin and vasopressin by way of a protein complex. J Biol Chem 233(1):116\u2013120","journal-title":"J Biol Chem"},{"key":"21_CR3_21","first-page":"F463","volume":"265","author":"P Agre","year":"1993","unstructured":"Agre P, Preston GM, Smith BL, Jung JS, Raina S, Moon C, Guggino WB, Nielsen S (1993) Aquaporin CHIP: the archetypal molecular channel. Am J Physiol 265:F463\u2013F476","journal-title":"Am J Physiol"},{"key":"21_CR4_21","doi-asserted-by":"publisher","first-page":"14659","DOI":"10.1074\/jbc.273.24.14659","volume":"273","author":"P Agre","year":"1998","unstructured":"Agre P, Bonhivers M, Borgnia MJ (1998) The aquaporins, blueprints for cellular plumbing systems. J Bio Chem 273:14659\u201314662","journal-title":"J Bio Chem"},{"key":"21_CR5_21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0167-0115(00)00196-8","volume":"96","author":"G Aguilera","year":"2000","unstructured":"Aguilera G, Rabadan-Diehl C (2000) Vasopressinergic regulation of the hypothalamic\u2013pituitary\u2013adrenal axis: implications for stress adaptation. Regul Pept 96:23\u201329","journal-title":"Regul Pept"},{"key":"21_CR6_21","doi-asserted-by":"crossref","unstructured":"Alloussi SH, M\u00fcrtz G, Lang C, Madersbacher H, Strugala G, Seibold J, Schwentner C, Stenzl A, Alloussi S. Desmopressin treatment regimens in monosymptomatic and nonmonosymptomatic enuresis: a review from a clinical perspective. J Pediatr Urol. 2010 [Epub] Accessed 01st August 2010","DOI":"10.1016\/j.jpurol.2010.04.014"},{"issue":"3","key":"21_CR7_21","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0196-9781(84)90080-9","volume":"5","author":"FA Antoni","year":"1984","unstructured":"Antoni FA, Holmes MC, Makara GB, K\u00e1rteszi M, L\u00e1szl\u00f3 FA (1984) Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor. Peptides 5(3):519\u2013522","journal-title":"Peptides"},{"key":"21_CR8_21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1254\/jphs.08R17FM","volume":"109","author":"Y Arai","year":"2009","unstructured":"Arai Y, Fujimori A, Sasamata M, Miyata K (2009) New topics in vasopressin receptors and approach to novel drugs: research and development of Conivaptan hydrochloride (YM087), a drug for the treatment of hyponatremia. J Pharmacol Sci 109:53\u201359","journal-title":"J Pharmacol Sci"},{"issue":"5","key":"21_CR9_21","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1046\/j.1464-410X.1998.00849.x","volume":"82","author":"R Asplund","year":"1998","unstructured":"Asplund R, Sundberg B, Bengtsson P (1998) Desmopressin for the treatment of nocturnal polyuria in the elderly: a dose titration study. Br J Urol 82(5):642\u2013646, Level 2b","journal-title":"Br J Urol"},{"key":"21_CR10_21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1046\/j.1464-410x.1999.00012.x","volume":"83","author":"R Asplund","year":"1999","unstructured":"Asplund R, Sundberg B, Bengtsson P (1999) Oral desmopressin for nocturnal polyuria in elderly subjects: a double-blind, placebo-controlled randomized exploratory study. BJU Int 83:591\u2013595 (Level 1b)","journal-title":"BJU Int"},{"issue":"1","key":"21_CR11_21","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.juro.2007.03.042","volume":"178","author":"JH Bae","year":"2007","unstructured":"Bae JH, Oh MM, Shim KS, Cheon J, Lee JG, Kim JJ, Moon DG (2007) The effects of long-term administration of oral desmopressin on the baseline secretion of antidiuretic hormone and serum sodium concentration for the treatment of nocturia: a circadian study. J Urol 178(1):200\u2013203","journal-title":"J Urol"},{"key":"21_CR12_21","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0022-3565(24)36848-X","volume":"282","author":"A Bernat","year":"1997","unstructured":"Bernat A, Hoffmann T, Dumas A et al (1997) V2 receptor antagonism of DDAVP-induced release of hemostatis factors in conscious dogs. J Pharmacol Exp Ther 282:597\u2013602","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"21_CR13_21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S1043-2760(00)00304-0","volume":"11","author":"M Birnbaumer","year":"2000","unstructured":"Birnbaumer M (2000) Vasopressin receptors. Trends Endocrinol Metab 11(10):406\u2013410","journal-title":"Trends Endocrinol Metab"},{"key":"21_CR14_21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ejphar.2007.03.022","volume":"566","author":"JI Birumachi","year":"2007","unstructured":"Birumachi JI, Hiroyama M, Fujiwara Y, Aoyagi T, Sanbe A, Tanoue A (2007) Impaired arginine-vasopressin-induced aldosterone release from adrenal gland cells in mice lacking the vasopressin V1A receptor. Eur J Pharmacol 566:226\u2013230","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"21_CR15_21","doi-asserted-by":"publisher","first-page":"e5573","DOI":"10.1371\/journal.pone.0005573","volume":"4","author":"I B\u00f6selt","year":"2009","unstructured":"B\u00f6selt I, R\u00f6mpler H, Hermsdorf T, Thor D, Busch W et al (2009) Involvement of the V2 vasopressin receptor in adaptation to limited water supply. PLoS One 4(5):e5573. doi:10.1371\/journal.pone.0005573. Accessed online on 26th July, 2009","journal-title":"PLoS One"},{"issue":"4","key":"21_CR16_21","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.urology.2009.05.033","volume":"74","author":"B Burgu","year":"2009","unstructured":"Burgu B, G\u00f6kce MI, G\u00fcc\u00fck A, Soyg\u00fcr T (2009) Prospective evaluation of factors affecting the response and relapse rates to desmopressin therapy in male monosymptomatic enuretic adults. Urology 74(4):915\u2013919","journal-title":"Urology"},{"key":"21_CR17_21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000051417","volume":"59","author":"AK Burroughs","year":"1998","unstructured":"Burroughs AK (1998) Pharmacological treatment of acute variceal bleeding. Digestion 59:28\u201336","journal-title":"Digestion"},{"key":"21_CR18_21","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0006-3495(97)78080-9","volume":"73","author":"V Cabiaux","year":"1997","unstructured":"Cabiaux V, Oberg KA, Pancoska P, Walz T, Agre P, Engel A (1997) Secondary structures comparison of aquaporin-1 and bacteriorhodopsin: a Fourier transform infrared spectroscopy study of two-dimensional membrane crystals. Biophys J 73:406\u2013417","journal-title":"Biophys J"},{"issue":"3","key":"21_CR19_21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1046\/j.1464-410x.1999.00195.x","volume":"84","author":"P Caione","year":"1999","unstructured":"Caione P, Nappo S, De Castro R, Prestipino M, Capozza N (1999) Low-dose desmopressin in the treatment of nocturnal urinary incontinence in the exstrophy\u2013epispadias complex. BJU Int 84(3):329\u2013334","journal-title":"BJU Int"},{"issue":"1","key":"21_CR20_21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2007.10.007","volume":"84","author":"HK Caldwell","year":"2008","unstructured":"Caldwell HK, Lee HJ, Macbeth AH, Young WS (2008) Vasopressin: behavioral roles of an \u2018original\u2019 neuropeptide. Prog Neurobiol 84(1):1\u201324","journal-title":"Prog Neurobiol"},{"key":"21_CR21_21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1046\/j.1464-410x.1999.00125.x","volume":"84","author":"A Cannon","year":"1999","unstructured":"Cannon A, Carter PG, McConnell AA, Abrams P (1999) Desmopressin in the treatment of nocturnal polyuria in the male. BJU Int 84:20\u201324, Level 1b","journal-title":"BJU Int"},{"issue":"4","key":"21_CR22_21","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/01952307.1994.11735930","volume":"17","author":"MB Chancellor","year":"1994","unstructured":"Chancellor MB, Rivas DA, Staas WE Jr (1994) DDAVP in the urological management of the difficult neurogenic bladder in spinal cord injury: preliminary report. J Am Paraplegia Soc 17(4):165\u2013167","journal-title":"J Am Paraplegia Soc"},{"issue":"4","key":"21_CR23_21","first-page":"191","volume":"5","author":"MB Chancellor","year":"1999","unstructured":"Chancellor MB, Atan A, Rivas DA, Watanabe T, Tai HL, Kumon H (1999) Beneficial effect of intranasal desmopressin for men with benign prostatic hyperplasia and nocturia: preliminary results. Tech Urol 5(4):191\u2013194 (Level 2b)","journal-title":"Tech Urol"},{"key":"21_CR24_21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/42517","volume":"387","author":"A Cheng","year":"1997","unstructured":"Cheng A, van Hoek AN, Yeager M, Verkman AS, Mitra AK (1997) Three-dimensional organization of a human water channel. Nature 387:627\u2013630","journal-title":"Nature"},{"key":"21_CR25_21","first-page":"R1235","volume":"263","author":"RA Cridland","year":"1992","unstructured":"Cridland RA, Kasting NW (1992) A critical role for central vasopressin in regulation of fever during bacterial infection. Am J Physiol 263:R1235\u2013R1240","journal-title":"Am J Physiol"},{"key":"21_CR26_21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0167-0115(93)90193-C","volume":"45","author":"R Dantzer","year":"1993","unstructured":"Dantzer R, Bluth\u00e9 RM (1993) Vasopressin and behaviour: from memory to olfaction. Regul Pept 45:121\u2013125","journal-title":"Regul Pept"},{"issue":"9624","key":"21_CR27_21","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/S0140-6736(08)60695-9","volume":"371","author":"G Decaux","year":"2008","unstructured":"Decaux G, Soupart A, Vassart G (2008) Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 371(9624):1624\u20131632","journal-title":"Lancet"},{"issue":"8024","key":"21_CR28_21","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0140-6736(77)92467-9","volume":"1","author":"SB Dimson","year":"1977","unstructured":"Dimson SB (1977) Desmopressin as a treatment for enuresis. Lancet 1(8024):1260","journal-title":"Lancet"},{"key":"21_CR29_21","first-page":"1","volume":"50","author":"V Du Vigneaud","year":"1954","unstructured":"Du Vigneaud V (1954) Hormones of the posterior pituitary gland: oxytocin and vasopressin. Harvey Lect 50:1\u201326","journal-title":"Harvey Lect"},{"key":"21_CR30_21","doi-asserted-by":"crossref","first-page":"F663","DOI":"10.1152\/ajprenal.1995.269.5.F663","volume":"269","author":"CA Ecelbarger","year":"1995","unstructured":"Ecelbarger CA, Terris J, Frindt G, Echevarria M, Marples D, Nielsen S, Knepper MA (1995) Aquaporin-3 water channel localization and regulation in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 269:F663\u2013F672","journal-title":"Am J Physiol Renal Fluid Electrolyte Physiol"},{"key":"21_CR31_21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1006\/exnr.2001.7775","volume":"171","author":"CA Ecelbarger","year":"2001","unstructured":"Ecelbarger CA, Kim GH, Wade JB, Knepper MA (2001) Regulation of the abundance of renal sodium transporters and channels by vasopressin. Exp Neurol 171:227\u2013234","journal-title":"Exp Neurol"},{"key":"21_CR32_21","doi-asserted-by":"publisher","first-page":"10997","DOI":"10.1073\/pnas.91.23.10997","volume":"91","author":"M Echevarria","year":"1994","unstructured":"Echevarria M, Windhager EE, Tate SS, Frindt G (1994) Cloning and expression of AQP3, a water channel from the medullary collecting duct of rat kidney. Proc Natl Acad Sci USA 91:10997\u201311001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"21_CR33_21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/j.1464-410X.1994.tb07116.x","volume":"74","author":"SD Eckford","year":"1994","unstructured":"Eckford SD, Swami KS, Jackson SR, Abrams PH (1994) Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis. Br J Urol 74(6):733\u2013735","journal-title":"Br J Urol"},{"issue":"4","key":"21_CR34_21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1464-410X.1995.tb07745.x","volume":"76","author":"SD Eckford","year":"1995","unstructured":"Eckford SD, Carter PG, Jackson SR, Penney MD, Abrams P (1995) An open, in-patient incremental safety and efficacy study of desmopressin in women with multiple sclerosis and nocturia. Br J Urol 76(4):459\u2013463","journal-title":"Br J Urol"},{"key":"21_CR35_21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1254\/jphs.08R14FM","volume":"109","author":"N Egashira","year":"2009","unstructured":"Egashira N, Mishima K, Iwasaki K, Oishi R, Fujiwara M (2009) New topics in vasopressin receptors and approach to novel drugs: Role of the vasopressin receptors in psychological and cognitive functions. J Pharmacol Sci 109:44\u201349","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"21_CR36_21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1345\/aph.17158","volume":"32","author":"E Ferreira","year":"1998","unstructured":"Ferreira E, Letwin SR (1998) Desmopressin for nocturia and enuresis associated with multiple sclerosis. Ann Pharmacother 32(1):114\u2013116","journal-title":"Ann Pharmacother"},{"issue":"2","key":"21_CR37_21","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1365-2265.1993.tb00990.x","volume":"38","author":"A Fjellestad-Paulsen","year":"1993","unstructured":"Fjellestad-Paulsen A, Hoglund P, Lundin S, Paulsen O (1993) Pharmacokinetics of 1-deamino-8-d-arginine vasopressin after various routes of administration in healthy volunteers. Clin Endocrinol (Oxf) 38(2):177\u2013182","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"21_CR38_21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1600-0404.1996.tb00035.x","volume":"94","author":"S Fredrikson","year":"1996","unstructured":"Fredrikson S (1996) Nasal spray desmopressin treatment of bladder dysfunction in patients with multiple sclerosis. Acta Neurol Scand 94(1):31\u201334","journal-title":"Acta Neurol Scand"},{"key":"21_CR39_21","doi-asserted-by":"publisher","first-page":"26946","DOI":"10.1074\/jbc.M303435200","volume":"278","author":"I Giminz","year":"2003","unstructured":"Giminz I, Forbush B (2003) Short-term stimulation of the renal Na\u2013K\u2013Cl cotransporter (NKCC2) by vasopressin involves phosphorylation and membrane translocation of the protein. J Biol Chem 278:26946\u201326951","journal-title":"J Biol Chem"},{"issue":"2","key":"21_CR40_21","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.3949\/ccjm.73.Suppl_2.S20","volume":"73","author":"S Goldsmith","year":"2006","unstructured":"Goldsmith S (2006) Vasopressin receptor antagonists: mechanisms of action and potential effects in heart failure. Cleve Clin J Med 73(2):S20\u2013S23","journal-title":"Cleve Clin J Med"},{"key":"21_CR41_21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/00000441-200001000-00002","volume":"319","author":"A Greenberg","year":"2000","unstructured":"Greenberg A (2000) Diuretic complications. Am J Med Sci 319:10","journal-title":"Am J Med Sci"},{"key":"21_CR42_21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1742-1241.2007.01247.x","volume":"155","author":"H Hashim","year":"2007","unstructured":"Hashim H, Abrams P (2007) Novel uses for antidiuresis. Int J Clin Pract Suppl 155:32\u201336","journal-title":"Int J Clin Pract Suppl"},{"issue":"1","key":"21_CR43_21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/nau.20613","volume":"28","author":"H Hashim","year":"2009","unstructured":"Hashim H, Malmberg L, Graugaard-Jensen C, Abrams P (2009) Desmopressin, as a \u2018designer-drug\u2019, in the treatment of overactive bladder syndrome. Neurourol Urodyn 28(1):40\u201346","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"21_CR44_21","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1210\/en.142.4.1659","volume":"142","author":"F Hernando","year":"2001","unstructured":"Hernando F, Schoots O, Lolait SJ, Burbach JP (2001) Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. Endocrinology 142(4):1659\u20131668","journal-title":"Endocrinology"},{"issue":"9","key":"21_CR45_21","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/jnnp.46.9.854","volume":"46","author":"P Hilton","year":"1983","unstructured":"Hilton P, Hertogs K, Stanton SL (1983) The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis. J Neurol Neurosurg Psychiatr 46(9):854\u2013855","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"21_CR46_21","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1113\/jphysiol.2007.129569","volume":"581","author":"H Hiroyama","year":"2007","unstructured":"Hiroyama M, Aoyagi T, Fujiwara Y, Oshikawa S, Sanbe A, Endo F et al (2007a) Hyperammonemia in V1a vasopressin receptor knockout mice caused by the promoted proteolysis and reduced intrahepatic blood volume. J Physiol 581:1183\u20131192","journal-title":"J Physiol"},{"key":"21_CR47_21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1210\/me.2006-0069","volume":"21","author":"M Hiroyama","year":"2007","unstructured":"Hiroyama M, Aoyagi T, Fujiwara Y, Birumachi J, Shigematsu Y, Kiwaki K et al (2007b) Hypermetabolism of fat in V1a vasopressin receptor knockout mice. Mol Endocrinol 21:247\u2013258","journal-title":"Mol Endocrinol"},{"key":"21_CR48_21","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1080\/00365599950510274","volume":"202","author":"K Hjalmas","year":"1999","unstructured":"Hjalmas K (1999) Desmopressin treatment: current status. Scand J Urol Nephrol Suppl 202:70\u201372","journal-title":"Scand J Urol Nephrol Suppl"},{"key":"21_CR49_21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1254\/jphs.08R30FM","volume":"109","author":"K Honda","year":"2009","unstructured":"Honda K, Takano Y (2009) New topics in vasopressin receptors and approach to novel drugs: Involvement of vasopressin V1a and V1b receptors in nociceptive responses and morphine-induced effects. J Pharmacol Sci 109:38\u201343","journal-title":"J Pharmacol Sci"},{"key":"21_CR50_21","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1136\/jnnp.65.5.778","volume":"65","author":"PA Hoverd","year":"1998","unstructured":"Hoverd PA, Fowler CJ (1998) Desmopressin in the treatment of daytime urinary frequency in patients with multiple sclerosis. J Neurol Neurosurg Psychiatr 65:778\u2013780","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"6","key":"21_CR51_21","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1464-410X.2005.05405.x","volume":"95","author":"GM Hvistendahl","year":"2005","unstructured":"Hvistendahl GM, Riis A, Norgaard JP, Djurhuus JC (2005) The pharmacokinetics of 400 microg of oral desmopressin in elderly patients with nocturia, and the correlation between the absorption of desmopressin and clinical effect. BJU Int 95(6):804\u2013809","journal-title":"BJU Int"},{"key":"21_CR52_21","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.bbamem.2006.09.029","volume":"1768","author":"PA Insel","year":"2007","unstructured":"Insel PA, Tang CM, Hahntow I, Michel MC (2007) Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targets \u2013 a review. Biochimica Biophysica Acta 1768:994\u20131005","journal-title":"Biochimica Biophysica Acta"},{"key":"21_CR53_21","unstructured":"Jackson EK (2006). Vasopressin and other agents affecting the renal conservation of water. In: Goodman and Gilman\u2019s The Pharmacological Basis of Therapeutics. 11th edition. The McGraw-Hill companies. United States of America"},{"key":"21_CR54_21","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0889-8529(03)00004-5","volume":"32","author":"N Janicic","year":"2003","unstructured":"Janicic N, Verbalis JG (2003) Evaluation and management of hypo-osmolality in hospitalized patients. Endocrinol Metab Clin North Am 32:459\u2013481","journal-title":"Endocrinol Metab Clin North Am"},{"key":"21_CR55_21","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/S0021-9258(18)81197-8","volume":"238","author":"RDJ Kimbrough","year":"1963","unstructured":"Kimbrough RDJ, Cash WD, Branda LA, Chan WY, Du Vigneaud V (1963) Synthesis and biological properties of 1-desamino-8-lysine-vasopressin. J Biol Chem 238:1411\u20131414","journal-title":"J Biol Chem"},{"key":"21_CR56_21","volume-title":"Concepts of genetics","author":"WS Klug","year":"2000","unstructured":"Klug WS, Cummings MR (2000) Concepts of genetics, 6th edn. Prentice Hall, Upper Saddle River","edition":"6"},{"key":"21_CR57_21","doi-asserted-by":"crossref","first-page":"F3","DOI":"10.1152\/ajprenal.1997.272.1.F3","volume":"272","author":"MA Knepper","year":"1997","unstructured":"Knepper MA (1997) Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. Am J Physiol Renal Physiol 272:F3\u2013F12","journal-title":"Am J Physiol Renal Physiol"},{"key":"21_CR58_21","first-page":"302","volume":"14","author":"MA Knepper","year":"1994","unstructured":"Knepper MA, Nielsen S, Chou CL, Digiovanni SR (1994) Mechanism of vasopressin action in the renal collecting duct. Semin Nephrol 14:302\u2013321","journal-title":"Semin Nephrol"},{"key":"21_CR59_21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1254\/jphs.08R18FM","volume":"109","author":"A Koshimizu","year":"2009","unstructured":"Koshimizu A, Tsujimoto G (2009) New topics in vasopressin receptors and approach to novel drugs: Vasopressin and pain perception. J Pharmacol Sci 109:33\u201337","journal-title":"J Pharmacol Sci"},{"key":"21_CR60_21","volume-title":"Textbook of endocrinology","year":"2002","unstructured":"Kronenberg HM, Melmed S, Polonsky KS (eds) (2002) Textbook of endocrinology, 10th edn. Elsevier, Philadelphia","edition":"10"},{"issue":"2","key":"21_CR61_21","doi-asserted-by":"publisher","first-page":"206.1","DOI":"10.1186\/gb-2006-7-2-206","volume":"7","author":"E Kruse","year":"2006","unstructured":"Kruse E, Uehlein N, Kaldenhoff R (2006) The aquaporins. Protein family review. Genome Biol 7(2):206.1\u2013206.6","journal-title":"Genome Biol"},{"key":"21_CR62_21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0090-4295(01)01645-4","volume":"59","author":"HC Kuo","year":"2002","unstructured":"Kuo HC (2002) Efficacy of desmopressin in treatment of refractory nocturia in patients older than 65 years. Urology 59:485\u2013489 (Level 2b)","journal-title":"Urology"},{"issue":"15","key":"21_CR63_21","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1007\/s00018-006-6054-2","volume":"63","author":"R Lemmens-Gruber","year":"2006","unstructured":"Lemmens-Gruber R, Kamyar M (2006) Vasopressin antagonists. Cell Mol Life Sci 63(15):1766\u20131779","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"21_CR64_21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1046\/j.1464-410x.2001.00068.x","volume":"87","author":"T Lopes","year":"2001","unstructured":"Lopes T, Dias JS, Marcelino J, Varela J, Ribeiro S, Dias J (2001) An assessment of the clinical efficacy of intranasal desmopressin spray in the treatment of renal colic. BJU Int 87(4):322\u2013325","journal-title":"BJU Int"},{"issue":"3","key":"21_CR65_21","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/01.ju.0000136203.76320.f6","volume":"172","author":"G Lose","year":"2004","unstructured":"Lose G, Mattiasson A, Walter S, Lalos O, van Kerrebroeck P, Abrams P, Freeman R (2004) Clinical experiences with desmopressin for long-term treatment of nocturia. J Urol 172(3):1021\u20131025","journal-title":"J Urol"},{"key":"21_CR66_21","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3109\/10799899909036676","volume":"19","author":"M Manning","year":"1999","unstructured":"Manning M, Stoev S, Cheng LL et al (1999) Discovery and design of novel vasopressin hypotensive peptide agonists. J Recept Signal Transduct Res 19:631\u2013644","journal-title":"J Recept Signal Transduct Res"},{"issue":"2","key":"21_CR67_21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/00365598009179551","volume":"14","author":"W Mansson","year":"1980","unstructured":"Mansson W, Sundin T, Gullberg B (1980) Evaluation of a synthetic vasopressin analogue for treatment of nocturia in benign prostatic hypertrophy. A double-blind study. Scand J Urol Nephrol 14(2):139\u2013141","journal-title":"Scand J Urol Nephrol"},{"issue":"9","key":"21_CR68_21","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1046\/j.1464-410X.2002.02791.x","volume":"89","author":"A Mattiasson","year":"2002","unstructured":"Mattiasson A, Abrams P, Van Kerrebroeck P, Walter S, Weiss J (2002) Efficacy of desmopressin in the treatment of nocturia: a double-blind placebo-controlled study in men. BJU Int 89(9):855\u2013862 (Level 1b)","journal-title":"BJU Int"},{"key":"21_CR69_21","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1042\/bst0070861","volume":"7","author":"RH Michell","year":"1979","unstructured":"Michell RH, Kirk CJ, Billah MM (1979) Hormonal stimulation of phosphatidylinositol breakdown with particular reference to the hepatic effects of vasopressin. Biochem Soc Trans 7:861\u2013865","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"21_CR70_21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000030346","volume":"62","author":"U Moro","year":"1999","unstructured":"Moro U, De Stefani S, Crisci A, De Antoni P, Scott CA, Selli C (1999) Evaluation of the effects of desmopressin in acute ureteral obstruction. Urol Int 62(1):8\u201311","journal-title":"Urol Int"},{"key":"21_CR71_21","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-3565(24)39000-7","volume":"295","author":"S Nakamura","year":"2000","unstructured":"Nakamura S, Hirano T, Tsujimae K et al (2000) Antidiuretic effects of a nonpeptide vasopressin V2-receptor agonist OPC-51803 administered orally to rats. J Pharmacol Exp Ther 295:1005\u20131011","journal-title":"J Pharmacol Exp Ther"},{"key":"21_CR72_21","doi-asserted-by":"publisher","first-page":"11663","DOI":"10.1073\/pnas.90.24.11663","volume":"90","author":"S Nielsen","year":"1993","unstructured":"Nielsen S, Digiovanni SR, Christensen EI, Knepper MA, Harris HW (1993) Cellular and subcellular immunolocalization of vasopressin regulated water channel in rat kidney. Proc Natl Acad Sci USA 90:11663\u201311667","journal-title":"Proc Natl Acad Sci USA"},{"key":"21_CR73_21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1681\/ASN.V103647","volume":"10","author":"S Nielsen","year":"1999","unstructured":"Nielsen S, Kwon TH, Christensen BM, Promeneur D, Frokier J, Marples D (1999) Physiology and pathophysiology of renal aquaporins. J Am Soc Nephrol 10:647\u2013663","journal-title":"J Am Soc Nephrol"},{"key":"21_CR74_21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1152\/physrev.00024.2001","volume":"82","author":"S Nielsen","year":"2002","unstructured":"Nielsen S, Frokier J, Marples D, Kwon TH, Age P, Knepper M (2002) Aquaporins in the kidney: from molecules to medicine. Physiol Rev 82:205\u2013244","journal-title":"Physiol Rev"},{"issue":"5","key":"21_CR75_21","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0022-5347(17)47581-1","volume":"134","author":"JP Norgaard","year":"1985","unstructured":"Norgaard JP, Pedersen EB, Djurhuus JC (1985) Diurnal anti-diuretic-hormone levels in enuretics. J Urol 134(5):1029\u20131031","journal-title":"J Urol"},{"key":"21_CR76_21","volume-title":"Miller-Keane encyclopedia & dictionary of medicine, nursing & allied health","year":"1992","unstructured":"O\u2019Toole M (ed) (1992) Miller-Keane encyclopedia & dictionary of medicine, nursing & allied health, 5th edn. Saunders, Philadelphia","edition":"5"},{"key":"21_CR77_21","first-page":"23","volume":"3.5","author":"M Oelke","year":"2010","unstructured":"Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, N\u2019Dow J, Nordling J, de la Rosette JJ (2010) Guidelines on conservative treatment of non-neurogenic male LUTS. EAU Guidelines 3.5:23\u201325","journal-title":"EAU Guidelines"},{"key":"21_CR78_21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","volume":"36","author":"R Ortega","year":"2002","unstructured":"Ortega R, Gin\u00e8s P, Uriz J et al (2002) Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study. Hepatology 36:941\u2013948","journal-title":"Hepatology"},{"key":"21_CR79_21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1124\/mol.65.3.623","volume":"65","author":"S Oshikawa","year":"2004","unstructured":"Oshikawa S, Tanoue A, Koshimizu T, Kitagawa Y, Tsujimoto G (2004) Vasopressin stimulates insulin release from islet cells through V1b receptors: a combined pharmacological\/knockout approach. Mol Pharmacol 65:623\u2013629","journal-title":"Mol Pharmacol"},{"issue":"635","key":"21_CR80_21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/pgmj.54.635.623","volume":"54","author":"PL Padfield","year":"1978","unstructured":"Padfield PL, Hodsman GP, Morton JJ (1978) Demeclocycline in the treatment of the syndrome of inappropriate antidiuretic hormone release: with measurement of plasma ADH. Postgrad Med J 54(635):623\u2013627","journal-title":"Postgrad Med J"},{"issue":"7 Suppl 1","key":"21_CR81_21","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1016\/j.amjmed.2006.05.014","volume":"119","author":"C Palm","year":"2006","unstructured":"Palm C, Pistrosch F, Herbrig K, Gross P (2006) Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia. Am J Med 119(7 Suppl 1):S87\u2013S92","journal-title":"Am J Med"},{"key":"21_CR82_21","unstructured":"Prasad S (2001). The role of the V2 vasopressin receptor in nephrogenic diabetes insipidus. Stanislaus Journal of biochemical reviews. http:\/\/wwwchem.csustan.edu\/chem4400\/sjbr\/Prasad01.htm. Accessed on 26th July, 2009"},{"issue":"8","key":"21_CR83_21","first-page":"675","volume":"17","author":"VN Puri","year":"1980","unstructured":"Puri VN (1980) Urinary levels of antidiuretic hormone in nocturnal enuresis. Indian Pediatr 17(8):675\u2013676","journal-title":"Indian Pediatr"},{"issue":"7","key":"21_CR84_21","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1046\/j.1464-410X.2003.04170.x","volume":"91","author":"A Rembratt","year":"2003","unstructured":"Rembratt A, Norgaard JP, Andersson KE (2003) Desmopressin in elderly patients with nocturia: short-term safety and effects on urine output, sleep and voiding patterns. BJU Int 91(7):642\u2013646 (Level 2b)","journal-title":"BJU Int"},{"issue":"6","key":"21_CR85_21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00228-004-0781-9","volume":"60","author":"A Rembratt","year":"2004","unstructured":"Rembratt A, Graugaard-Jensen C, Senderovitz T, Norgaard JP, Djurhuus JC (2004) Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55\u201370 years. Eur J Clin Pharmacol 60(6):397\u2013402 (Level 2b)","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"21_CR86_21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/nau.20168","volume":"25","author":"A Rembratt","year":"2006","unstructured":"Rembratt A, Riis A, Norgaard JP (2006) Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia. Neurourol Urodyn 25(2):105\u2013109 (Level 1b)","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"21_CR87_21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1046\/j.1365-2265.1998.00340.x","volume":"48","author":"S Rittig","year":"1998","unstructured":"Rittig S, Jensen AR, Jensen KT, Pedersen EB (1998) Effect of food intake on the pharmacokinetics and antidiuretic activity of oral desmopressin (DDAVP) in hydrated normal subjects. Clin Endocrinol (Oxf) 48(2):235\u2013241","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"21_CR88_21","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1111\/j.1464-410X.2004.04768.x","volume":"93","author":"D Robinson","year":"2004","unstructured":"Robinson D, Cardozo L, Akeson M, Hvistendahl G, Riis A, Norgaard JP (2004) Antidiuresis: a new concept in managing female daytime urinary incontinence. BJU Int 93(7):996\u20131000","journal-title":"BJU Int"},{"issue":"3","key":"21_CR89_21","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.urology.2008.05.053","volume":"75","author":"A Roshani","year":"2010","unstructured":"Roshani A, Falahatkar S, Khosropanah I, Roshan ZA, Zarkami T, Palizkar M, Emadi SA, Akbarpour M, Khaki N (2010) Assessment of clinical efficacy of intranasal desmopressin spray and diclofenac sodium suppository in treatment of renal colic versus diclofenac sodium alone. Urology 75(3):540\u2013542","journal-title":"Urology"},{"key":"21_CR90_21","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1124\/mol.106.029470","volume":"71","author":"GE Rovati","year":"2007","unstructured":"Rovati GE, Capra V, Neubig RR (2007) The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state. Mol Pharmacol 71:959\u2013964","journal-title":"Mol Pharmacol"},{"key":"21_CR91_21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s00232-002-1053-1","volume":"191","author":"JM Sands","year":"2003","unstructured":"Sands JM (2003) Molecular mechanisms of urea transport. J Membr Biol 191:149\u2013163","journal-title":"J. Membr Biol"},{"key":"21_CR92_21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.7326\/0003-4819-144-3-200602070-00007","volume":"144","author":"JM Sands","year":"2006","unstructured":"Sands JM, Bichet DG (2006) Nephrogenic diabetes insipidus. Ann Intern Med 144:186\u2013194","journal-title":"Ann Intern Med"},{"issue":"7 Suppl 1","key":"21_CR93_21","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.amjmed.2006.05.007","volume":"119","author":"RW Schrier","year":"2006","unstructured":"Schrier RW (2006) Water and sodium retention in oedematous disorders: role of vasopressin and aldosterone. Am J Med 119(7 Suppl 1):S47\u2013S53","journal-title":"Am J Med"},{"key":"21_CR94_21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/mol.54.3.525","volume":"54","author":"R Schulein","year":"1998","unstructured":"Schulein R, Hermosilla R, Oksche A, Dehe M, Wiesner B et al (1998) A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS. M6 cells. Mol Pharmacol 54:525\u2013535","journal-title":"Mol Pharmacol"},{"key":"21_CR95_21","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0165-0327(02)00026-5","volume":"72","author":"LV Scott","year":"2002","unstructured":"Scott LV, Dinan TG (2002) Vasopressin as a target for antidepressant development: an assessment of the available evidence. J Affect Disord 72:113\u2013124","journal-title":"J Affect Disord"},{"key":"21_CR96_21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0079-6123(02)39017-4","volume":"139","author":"C Serradeil-Le Gal","year":"2002","unstructured":"Serradeil-Le Gal C, Wagnon J, Valette G et al (2002a) Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands. Prog Brain Res 139:197\u2013210","journal-title":"Prog Brain Res"},{"key":"21_CR97_21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0079-6123(02)39017-4","volume":"139","author":"C Serradeil-Le Gal","year":"2002","unstructured":"Serradeil-Le Gal C, Wagnon J, Valette G, Garcia G, Pascal M, Maffrand JP, Le Fur G (2002b) Nonpeptide vasopressin receptor antagonists: development of selective and orally active V1a, V2 and V1b receptor ligands. Prog Brain Res 139:197\u2013210","journal-title":"Prog Brain Res"},{"key":"21_CR98_21","doi-asserted-by":"crossref","first-page":"C147","DOI":"10.1152\/ajpcell.1992.263.1.C147","volume":"263","author":"HM Snyder","year":"1992","unstructured":"Snyder HM, Noland TD, Breyer MD (1992) cAMP-dependent protein kinase mediates hydro-osmotic effect of vasopressin in collecting duct. Am J Physiol 263:C147\u2013C153","journal-title":"Am J Physiol"},{"key":"21_CR99_21","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1378\/chest.103.2.601","volume":"103","author":"M Sonnenblick","year":"1993","unstructured":"Sonnenblick M, Friedlander Y, Rosin AJ (1993) Diuretic-induced severe hyponatremia. Review and analysis of 129 reported patients. Chest 103:601\u2013606","journal-title":"Chest"},{"issue":"6","key":"21_CR100_21","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/j.1365-2362.1984.tb01209.x","volume":"14","author":"PS Sorensen","year":"1984","unstructured":"Sorensen PS, Vilhardt H, Gjerris F, Warberg J (1984) Impermeability of the blood\u2013cerebrospinal fluid barrier to 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus. Eur J Clin Invest 14(6):435\u2013439","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"21_CR101_21","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1159\/000123555","volume":"37","author":"H Stegner","year":"1983","unstructured":"Stegner H, Artman HG, Leake RD, Fisher DA (1983) Does DDAVP (1-desamino-8-d-arginine-vasopressin) cross the blood\u2013CSF barrier? Neuroendocrinology 37(4):262\u2013265","journal-title":"Neuroendocrinology"},{"key":"21_CR102_21","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0021-9258(18)81315-1","volume":"238","author":"RO Studer","year":"1963","unstructured":"Studer RO, Cash WD (1963) Synthesis of 1-acetyl-8-argininevasopressin and a study of its effects in the rat pressor assay. J Biol Chem 238:657\u2013659","journal-title":"J Biol Chem"},{"issue":"3","key":"21_CR103_21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/mds.870100318","volume":"10","author":"O Suchowersky","year":"1995","unstructured":"Suchowersky O, Furtado S, Rohs G (1995) Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson\u2019s disease. Mov Disord 10(3):337\u2013340","journal-title":"Mov Disord"},{"key":"21_CR104_21","doi-asserted-by":"crossref","first-page":"F775","DOI":"10.1152\/ajprenal.1995.269.6.F775","volume":"269","author":"J Terris","year":"1995","unstructured":"Terris J, Ecelbarger CA, Marples D, Knepper MA, Nielsen S (1995) Distribution of aquaporin-4 water channel expression within rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 269:F775\u2013F785","journal-title":"Am J Physiol Renal Fluid Electrolyte Physiol"},{"key":"21_CR105_21","doi-asserted-by":"crossref","first-page":"F414","DOI":"10.1152\/ajprenal.1996.271.2.F414","volume":"271","author":"J Terris","year":"1996","unstructured":"Terris J, Ecelbarger CA, Nielsen S, Knepper MA (1996) Long-term regulation of four renal aquaporins in rats. Am J Physiol Renal Physiol 271:F414\u2013F422","journal-title":"Am J Physiol Renal Physiol"},{"key":"21_CR106_21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0079-6123(02)39016-2","volume":"139","author":"M Thbonnier","year":"2002","unstructured":"Thbonnier M, Coles P, Thibionnier A, Shoham M (2002) Molecular pharmacology and modelling of vasopressin receptors. Prog Brain Res 139:179\u2013196","journal-title":"Prog Brain Res"},{"key":"21_CR107_21","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1254\/jphs.08R16FM","volume":"109","author":"G Tsujimoto","year":"2009","unstructured":"Tsujimoto G, Takano Y (2009) New topics in vasopressin receptors and approach to novel drugs: preface. J Pharmacol Sci 109:32","journal-title":"J Pharmacol Sci"},{"key":"21_CR108_21","first-page":"416","volume":"5","author":"N Tubridy","year":"1999","unstructured":"Tubridy N et al (1999) Long term use of desmopressin for urinary symptoms in multiple sclerosis. Mult Scler 5:416\u2013417","journal-title":"Mult Scler"},{"issue":"1","key":"21_CR109_21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0021-9258(18)50947-9","volume":"191","author":"RA Turner","year":"1951","unstructured":"Turner RA, Pierce JG, Du Vigneaud V (1951) The purification and the amino acid content of vasopressin preparations. J Biol Chem 191(1):21\u201328","journal-title":"J Biol Chem"},{"issue":"6","key":"21_CR110_21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1651-2227.1978.tb16255.x","volume":"67","author":"T Tuvemo","year":"1978","unstructured":"Tuvemo T (1978) DDAVP in childhood nocturnal enuresis. Acta Paediatr Scand 67(6):753\u2013755","journal-title":"Acta Paediatr Scand"},{"issue":"5","key":"21_CR111_21","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/ana.410310525","volume":"31","author":"G Valiquette","year":"1992","unstructured":"Valiquette G, Abrams GM, Herbert J (1992) DDAVP in the management of nocturia in multiple sclerosis. Ann Neurol 31(5):577","journal-title":"Ann Neurol"},{"issue":"12","key":"21_CR112_21","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/archneur.1996.00550120082020","volume":"53","author":"G Valiquette","year":"1996","unstructured":"Valiquette G, Herbert J, Maede-D'Alisera P (1996) Desmopressin in the management of nocturia in patients with multiple sclerosis. A double-blind, crossover trial. Arch Neurol 53(12):1270\u20131275","journal-title":"Arch Neurol"},{"issue":"4","key":"21_CR113_21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2165\/11319110-000000000-00000","volume":"33","author":"J Van de Walle","year":"2010","unstructured":"Van de Walle J, Van Herzeele C, Raes A (2010) Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues. Drug Saf 33(4):261\u2013271","journal-title":"Drug Saf"},{"issue":"4 Suppl","key":"21_CR114_21","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.juro.2009.06.001","volume":"182","author":"C Van Herzeele","year":"2009","unstructured":"Van Herzeele C, Alova I, Evans J, Eggert P, Lottmann H, N\u00f8rgaard JP, Vande Walle J (2009) Poor compliance with primary nocturnal enuresis therapy may contribute to insufficient desmopressin response. J Urol 182(4 Suppl):2045\u20132049","journal-title":"J Urol"},{"key":"21_CR115_21","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s002329900438","volume":"165","author":"AN Van Hoek","year":"1998","unstructured":"Van Hoek AN, Yang B, Kirmiz S, Brown D (1998) Freeze-fracture analysis of plasma membranes of CHO cells stably expressing aquaporins 1\u20135. J Membr Biol 165:243\u2013254","journal-title":"J Membr Biol"},{"issue":"1","key":"21_CR116_21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.eururo.2007.01.027","volume":"52","author":"P van Kerrebroeck","year":"2007","unstructured":"van Kerrebroeck P, Rezapour M, Cortesse A, Th\u00fcroff J, Rijs A, Norgaard JP (2007) Desmopressin in the treatment of nocturia: a double blind placebo-controlled study. Eur Urol 52(1):221\u2013229 (Level 1b)","journal-title":"Eur Urol"},{"issue":"6","key":"21_CR117_21","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1111\/j.1742-1241.2010.02336.x","volume":"64","author":"P van Kerrebroeck","year":"2010","unstructured":"van Kerrebroeck P, Hashim H, Holm-Larsen T, Robinson D, Stanley N (2010) Thinking beyond the bladder: antidiuretic treatment of nocturia. Int J Clin Pract 64(6):807\u2013816","journal-title":"Int J Clin Pract"},{"issue":"1","key":"21_CR118_21","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0022-3565(25)29745-2","volume":"188","author":"I Vavra","year":"1974","unstructured":"Vavra I, Machova A, Krejci I (1974) Antidiuretic action of 1-deamino-(8-d-arginine)-vasopressin in unanesthetized rats. J Pharmacol Exp Ther 188(1):241\u2013247","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"21_CR119_21","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.3949\/ccjm.73.Suppl_3.S24","volume":"73","author":"JG Verbalis","year":"2006","unstructured":"Verbalis JG (2006) AVP receptor antagonists as aquaretics: review and assessment of clinical data. Cleve Clin J Med 73(3):S24\u2013S33","journal-title":"Cleve Clin J Med"},{"issue":"4","key":"21_CR120_21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0306-3623(86)90198-9","volume":"17","author":"H Vilhardt","year":"1986","unstructured":"Vilhardt H, Lundin S (1986) Biological effect and plasma concentrations of DDAVP after intranasal and peroral administration to humans. Gen Pharmacol 17(4):481\u2013483","journal-title":"Gen Pharmacol"},{"key":"21_CR121_21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/00042737-200104000-00006","volume":"13","author":"P Vlavianos","year":"2001","unstructured":"Vlavianos P, Westaby D (2001) Management of acute variceal haemorrhage. Eur J Gastroenterol Hepatol 13:335\u2013342","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"21_CR122_21","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1111\/j.1464-410X.2009.08872.x","volume":"105","author":"M Vogt","year":"2010","unstructured":"Vogt M, Lehnert T, Till H, Rolle U (2010) Evaluation of different modes of combined therapy in children with monosymptomatic nocturnal enuresis. BJU Int 105(10):1456\u20131459","journal-title":"BJU Int"},{"key":"21_CR123_21","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/42512","volume":"387","author":"T Walz","year":"1997","unstructured":"Walz T, Hirai T, Murata K, Heymann JB, Mitsuoka K, Fujiyoshi Y, Smith BL, Agre P, Engel A (1997) The three-dimensional structure of aquaporin-1. Nature 387:624\u2013627","journal-title":"Nature"},{"issue":"4","key":"21_CR124_21","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/nau.20038","volume":"23","author":"M Weatherall","year":"2004","unstructured":"Weatherall M (2004) The risk of hyponatremia in older adults using desmopressin for nocturia: a systematic review and meta-analysis. Neurourol Urodyn 23(4):302\u2013305 (Level 1a)","journal-title":"Neurourol Urodyn"},{"key":"21_CR125_21","doi-asserted-by":"publisher","first-page":"47254","DOI":"10.1074\/jbc.M408154200","volume":"279","author":"S Wuller","year":"2004","unstructured":"Wuller S, Wiesner B, Loffler A, Furkert J, Krause G, Hermosilla R, Schaefer M, Schulein R, Rosenthal W, Oksche A (2004) Pharmacochaperones post-translationally enhance cell surface expression by increasing conformational stability of wild-type and mutant vasopressin V2 receptors. J Biol Chem 279:47254\u201347263","journal-title":"J Biol Chem"},{"key":"21_CR126_21","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1074\/jbc.271.9.4577","volume":"271","author":"B Yang","year":"1996","unstructured":"Yang B, Brown D, Verkman AS (1996) The mercurial insensitive water channel (AQP-4) forms orthogonal arrays in stably transfected Chinese hamster ovary cells. J Biol Chem 271:4577\u20134580","journal-title":"J Biol Chem"},{"key":"21_CR127_21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0166-2236(97)01167-3","volume":"21","author":"LJ Young","year":"1998","unstructured":"Young LJ, Wang Z, Insel TR (1998) Neuroendocrine bases of monogamy. Trends Neurosci 21:71\u201375","journal-title":"Trends Neurosci"},{"issue":"4","key":"21_CR128_21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuroscience.2006.08.040","volume":"143","author":"WS Young","year":"2006","unstructured":"Young WS, Li J, Wersinger SR, Palkovits M (2006) The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy. Neuroscience 143(4):1031\u20131039","journal-title":"Neuroscience"},{"issue":"1","key":"21_CR129_21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11255-007-9232-8","volume":"40","author":"A Zahariou","year":"2008","unstructured":"Zahariou A, Karamouti M, Karagiannis G, Papaioannou P (2008) Maximal bladder capacity is a positive predictor of response to desmopressin treatment in patients with MS and nocturia. Int Urol Nephrol 40(1):65\u201369","journal-title":"Int Urol Nephrol"},{"key":"21_CR130_21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2337\/diabetes.28.5.503","volume":"28","author":"RL Zerbe","year":"1979","unstructured":"Zerbe RL, Vinicor F, Robertson GL (1979) Plasma vasopressin in uncontrolled diabetes mellitus. Diabetes 28:503\u2013508","journal-title":"Diabetes"}],"container-title":["Handbook of Experimental Pharmacology","Urinary Tract"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-16499-6_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T04:44:21Z","timestamp":1740890661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-16499-6_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"ISBN":["9783642164989","9783642164996"],"references-count":130,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-16499-6_21","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-642-16499-6","asserted-by":"object"}]},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]},"assertion":[{"value":"19 January 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}